Transient metabolic improvement in obese mice treated with navitoclax or dasatinib/quercetin
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Senescent cells accumulate with obesity in the white adipose tissue of mice and humans.These senescent cells enhance the pro-inflammatory environment that, with time, contributes to the onset of glucose intolerance and type 2 diabetes.Glucose intolerance in mouse models of obesity has been successfully reversed by the elimination of senescent cells with the senolytic compounds navitoclax or the combination of dasatinib and quercetin (D/Q).In this work, we generated obese mice by high-fat diet feeding, and treated them with five consecutive cycles of navitoclax or D/Q during 16 weeks.We observed an efficient reduction in the white adipose tissue of the senescence markers senescence-associated β-galactosidase activity, Cdkn2a-p16 and Cdkn2a-p19 at the end of the 5 cycles.Mice treated with both navitoclax and D/Q showed an improvement of their insulin sensitivity and glucose tolerance during a short period of time (cycles 3 and 4), that disappeared at the fifth cycle.Also, these mice tended to increase the expression at their adipose tissue of the adipogenic genes Pparg and, Cebpa, as well as their plasma adiponectin levels.Together, our work shows that two different senolytic treatments, acting through independent pathways, are transiently effective in the treatment of obesity-induced metabolic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 2×
“Baker and collaborators demonstrated for the first time that removal of senescent cells is beneficial for age-related diseases, using a mouse model that specifically eliminates Cdkn2a-p16-positive cells, named INK-ATTAC [15].”
BackgroundCellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584 · cited 1×
“The description of the first senolytic treatments by the combination of dasatinib with quercetin in vitro [17], or the inhibitor of the Bcl-2 family of antiapoptotic proteins navitoclax [18], was followed by many other new, and still less studied senolytic compounds [19– 21].”
BackgroundSenolytics improve physical function and increase lifespan in old age
Xu, M., Pirtskhalava, T., Farr, J. N., Weigand, B. M., Palmer, A. K., Weivoda, M. M., Inman, C. L., Ogrodnik, M. B., Hachfeld, C. M., Fraser, D. G., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0092-9 · Cited by 2,287
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J., & Kirkland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64098 · Cited by 1,774 · cited 1×
“In a healthy scenario, SASP acts in both an autocrine and a paracrine manner to create an inflammatory environment that attracts immune cells to clear senescent cells and promote tissue regeneration [13].”
BackgroundDebacq-Chainiaux, F., Erusalimsky, J. D., Campisi, J., & Toussaint, O. (2009) · Nature Protocols · doi:10.1038/nprot.2009.191 · Cited by 1,668
Zhu, Y., Tchkonia, T., Fuhrmann‐Stroissnigg, H., Dai, H. M., Ling, Y. Y., Stout, M. B., Pirtskhalava, T., Giorgadze, N., Johnson, K. O., Giles, C. B., et al. (2016) · Aging Cell · doi:10.1111/acel.12445 · Cited by 1,148 · cited 1×
“The description of the first senolytic treatments by the combination of dasatinib with quercetin in vitro [17], or the inhibitor of the Bcl-2 family of antiapoptotic proteins navitoclax [18], was followed by many other new, and still less studied senolytic compounds [19– 21].”
BackgroundFat tissue, aging, and cellular senescence
Tchkonia, T., Morbeck, D. E., Von Zglinicki, T., Van Deursen, J., Lustgarten, J., Scrable, H., Khosla, S., Jensen, M. D., & Kirkland, J. L. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00608.x · Cited by 1,094 · cited 1×
“important role in obesity [32], obesity-induced anxiety and impaired neurogenesis [33] and in type 2 diabetes [3, 4].”
BackgroundZhang, P., Kishimoto, Y., Grammatikakis, I., Gottimukkala, K., Cutler, R. G., Zhang, S., Abdelmohsen, K., Bohr, V. A., Misra Sen, J., Gorospe, M., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0372-9 · Cited by 977
Cellular senescence and tumor suppressor gene p16
Rayess, H., Wang, M. B., & Srivatsan, E. S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27316 · Cited by 825 · cited 1×
“genes, the best known of which are the tumor suppressors Cdkn2a-p16, Cdkn2a-p19, Cdkn1b-p27, Cdkn2b-p15 or Cdkn1a-p21, resulting in proliferative arrest [9, 10].”
Background
Research works printed but not linked: 17
- Qi, 2012, Mechanisms of inflammatory responses in obese adipose tissue., Annu Rev Nutr, 3, 261, 10.1146/annurev-nutr-071811-150623 · DOI · Paper page
- Komuro, 2009, A crucial role for adipose tissue p53 in the regulation of insulin resistance., Nat Med, 1, 1082, 10.1038/nm.2014 · DOI · Paper page
- Bonner-Weir, 2019, Acceleration of β cell aging determines diabetes and senolysis improves disease outcomes., Cell Metab, 3, 129, 10.1016/j.cmet.2019.05.006 · DOI · Paper page
- Moorhead, 1961, The serial cultivation of human diploid cell strains., Exp Cell Res, 2, 585, 10.1016/0014-4827(61)90192-6 · DOI · Paper page
- Demaria, 2018, Hallmarks of cellular senescence., Trends Cell Biol, 2, 436, 10.1016/j.tcb.2018.02.001 · DOI · Paper page
- Pereira-Smith, 1995, A biomarker that identifies senescent human cells in culture and in aging skin in vivo., Proc Natl Acad Sci USA, 9, 9363, 10.1073/pnas.92.20.9363 · DOI · Paper page
- Campisi, 2010, The senescence-associated secretory phenotype: the dark side of tumor suppression., Annu Rev Pathol, 5, 99, 10.1146/annurev-pathol-121808-102144 · DOI · Paper page
- Zhang, 2019, Emerging senolytic agents derived from natural products., Mech Ageing Dev, 18, 1, 10.1016/j.mad.2019.05.001 · DOI · Paper page
- Muñoz-Espín, 2019, Targeting senescent cells in translational medicine., EMBO Mol Med, 1, e10234, 10.15252/emmm.201810234 · DOI · Paper page
- Elmore, 2006, The Bcl-2 Family Inhibitor ABT-263 Shows Significant but Reversible Thrombocytopenia in Mice., Blood, 10, 1107, 10.1182/blood.V108.11.825.825 · doi:10.1182/blood.v108.11.825.825
- Xiong, 2014, Mechanism-based pharmacokinetic/pharmacodynamic meta-analysis of navitoclax (ABT-263) induced thrombocytopenia., Cancer Chemother Pharmacol, 7, 593, 10.1007/s00280-014-2530-9 · DOI · Paper page
- Horio, 2006, Serum adiponectin concentration: its correlation with diabetes-related traits and quantitative trait loci analysis in mouse SMXA recombinant inbred strains., Biosci Biotechnol Biochem, 7, 677, 10.1271/bbb.70.677 · DOI
- Bustanji, 2015, Adiponectin serum levels correlate with insulin resistance in type 2 diabetic patients., Saudi Pharm J, 2, 250, 10.1016/j.jsps.2014.11.011 · DOI
- Kirkland, 2007, Aging results in paradoxical susceptibility of fat cell progenitors to lipotoxicity., Am J Physiol Endocrinol Metab, 29, E1041, 10.1152/ajpendo.00557.2006 · DOI · Paper page
- Faragher, 2018, Obesity and type-2 diabetes as inducers of premature cellular senescence and ageing., Biogerontology, 1, 447, 10.1007/s10522-018-9763-7 · DOI · Paper page
- Farmer, 1999, Reconstitution of insulin-sensitive glucose transport in fibroblasts requires expression of both PPARgamma and C/EBPalpha., J Biol Chem, 27, 7946, 10.1074/jbc.274.12.7946 · DOI · Paper page
- Spiegelman, 1999, Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity., Mol Cell, 3, 151, 10.1016/s1097-2765(00)80306-8 · DOI · Paper page
Cited by
Cellular senescence: a key therapeutic target in aging and diseases
Zhang, L., Pitcher, L. E., Yousefzadeh, M. J., Niedernhofer, L. J., Robbins, P. D., & Zhu, Y. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158450 · Cited by 631
Obese visceral fat tissue inflammation: from protective to detrimental?
Kolb, H. (2022) · BMC Medicine · doi:10.1186/s12916-022-02672-y · Cited by 353
Islam, M. T., Tuday, E., Allen, S., Kim, J., Trott, D. W., Holland, W. L., Donato, A. J., & Lesniewski, L. A. (2023) · Aging Cell · doi:10.1111/acel.13767 · Cited by 313
Current and investigational medications for the treatment of sarcopenia
Rolland, Y., Dray, C., Vellas, B., & Barreto, P. D. S. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155597 · Cited by 195
Raffaele, M., Kovacovicova, K., Frohlich, J., Lo Re, O., Giallongo, S., Oben, J. A., Faldyna, M., Leva, L., Giannone, A. G., Cabibi, D., et al. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00731-0 · Cited by 60
Cellular senescence as a driver of cognitive decline triggered by chronic unpredictable stress
Lin, Y.-F., Wang, L.-Y., Chen, C.-S., Li, C.-C., & Hsiao, Y.-H. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100341 · Cited by 47
“CUS-treated mice were gavaged with dasatinib (5 mg/kg) (LC Laboratories; Cat: # D-3307) and quercetin (50 mg/kg) (Sigma; Cat: #Q4951) or vehicle (60% Phosal, 10% ethanol, and 30% PEG-400) for 5 days a week for 2 weeks (Ogrodnik et al., 2019; Sierra-Ramirez et al., 2020).”
Metadata
- Authors
- Sierra-Ramirez, A., López-Aceituno, J. L., Costa-Machado, L. F., Plaza, A., Barradas, M., & Fernandez-Marcos, P. J.
- Venue
- Aging
- Publisher
- Impact Journals, LLC
- Published
- 2020-06-25
- Volume
- 12
- Issue
- 12
- Pages
- 11337-11348
- ISSN
- 1945-4589 (ISSN-L)
- OpenAlex
- W3037268978
- Cited by
- 47
- References
- 23
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.